Everest Medicines Announces the Launch of VELSIPITY® in the Guangdong-Hong Kong-Macau Greater Bay Area, Offering a New Option for Moderately to Severely Active Ulcerative Colitis Patients
SHANGHAI, Oct. 25, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that, throu
2024 Malaysia E-commerce Product Selection Expo Reaches Major Milestone Attracting Leading Brands and Businesses From China
KUALA LUMPUR, Malaysia, Oct. 25, 2024 /PRNewswire/ — In less than a month since its announcement, the inaugural 2024 Malaysia E-commerce Product Selection Expo, organized by JMM Exhibition, has garnered strong interest from China-based businesses. Numerous leading brands, enterprises, manufac
Camp Run-A-Mutt Expands to Henderson, NV
HENDERSON, Nev., Oct. 24, 2024 /PRNewswire/ — Camp Run-A-Mutt Entrepreneurial Resources is thrilled to announce the opening of its newest location (the first in Nevada), in the city of Henderson. Camp Run-A-Mutt is a cage-free dog daycare and boarding franchise known for its exceptional pet c
MEDIA ADVISORY – Minister Anandasangaree and Anishinabek Nation strengthen Indigenous-led education
NORTH BAY, ON, Oct. 24, 2024 /CNW/ – Please be advised that the Honourable Gary Anandasangaree, Minister of Crown-Indigenous Relations, along with Lise Kwekkeboom, Vice Chair of the Kinoomaadziwin Education Body Board, will make an announcement regarding self-governing, Anishinabek Nation-led
GA Telesis Signs Definitive Purchase Agreement to Acquire 23 Airbus A320ceo and A321ceo Aircraft from Spirit Airlines
FORT LAUDERDALE, Fla., Oct. 24, 2024 /PRNewswire/ — GA Telesis, LLC (“GA Telesis”), a global leader in commercial aviation and aerospace solutions, today announced it has signed a definitive purchase agreement and secured the necessary corporate approvals to acquire 23 used Airbus
Tyra Biosciences Reports Interim Clinical Proof-of-Concept Data for TYRA-300, an Investigational Oral FGFR3-Selective Inhibitor, in Phase 1/2 SURF301 Study in Patients with Metastatic Urothelial Cancer (mUC)
– Encouraging preliminary anti-tumor activity observed in heavily pre-treated population – – At ≥ 90 mg QD, 6 out of 11 (54.5%) patients with FGFR3+ mUC achieved a confirmed partial response (PR), with 100% disease control rate and sustained duration of activity – – P
Media Advisory – Prime Minister’s itinerary for Friday, October 25, 2024
OTTAWA, ON, Oct. 24, 2024 /CNW/ – Note: All times local Greater Toronto Region, Ontario The Prime Minister will visit a police station to discuss the drop in auto-theft incidents. Closed to media This document is also available at https://pm.gc.ca SOURCE Prime Minister’s Office
Pizzeria in a Tiny Wine Country Town Named One of the Bay Area’s Top 50 Restaurants
FORESTVILLE, Calif., Oct. 24, 2024 /PRNewswire/ — Sonoma Pizza Co., a beloved hidden gem pizzeria in the small wine country town of Forestville, has been recognized as one of the top 50 restaurants in the Bay Area by Yelp Elites, joining prestigious culinary establishments such as The French L
AKTIS ONCOLOGY ANNOUNCES PRESENTATION OF THE FIRST CLINICAL DATA SUPPORTING BROAD DEVELOPMENT OF A FIRST IN CLASS NECTIN-4 TARGETING RADIOPHARMACEUTICAL AKY-1189 AT 2024 EORTC-NCI-AACR SYMPOSIUM ON MOLECULAR TARGETS AND CANCER THERAPEUTICS
AKY-1189 is a novel Nectin-4 targeted radiopharmaceutical product candidate demonstrating substantial tumor uptake across several solid tumor types and is progressing in human development as a therapeutic agent AKY-1189 was engineered to deliver actinium-225 directly to tumors while minimizing expos
Community Healthcare Trust Incorporated Announces Increased Third Quarter Dividend
FRANKLIN, Tenn., Oct. 24, 2024 /PRNewswire/ — Community Healthcare Trust Incorporated (NYSE: CHCT) today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended September 30, 2024. This dividend, in the amount of $0.4650 per share, is payable o
